Showing 3981-3990 of 21451 results for "".
- Menstruation and Increased Vaso-Occlusive Pain in Females with Sickle Cell Diseasehttps://reachmd.com/news/menstruation-and-increased-vaso-occlusive-pain-in-females-with-sickle-cell-disease/2485763/Menstruation was described as a frequently reported time for disease-related pain among women and girls with sickle cell disease (SCD), and the report found that endorsement of menstrual-associated sickle cell pain was associated with higher acute care utilization over the prior six
- Early Hydrocortisone and Survival Without BPD in Extremely Preterm Infantshttps://reachmd.com/news/news-summary-early-hydrocortisone-and-survival-without-bpd-in-extremely-preterm-infants/2485766/A Swedish registry-based national historical cohort study reported a higher likelihood of survival without bronchopulmonary dysplasia among e
- Medtronic Stealth AXiS: FDA-Cleared Integrated Planning, Navigation, and Roboticshttps://reachmd.com/news/medtronic-stealth-axis-fda-cleared-integrated-planning-navigation-and-robotics/2485761/Medtronic’s announcement reports U.S. FDA clearance for the
- Ten‑Year Outcomes and Selection Issues for Salvage Focal Therapy After Radiorecurrencehttps://reachmd.com/news/tenyear-outcomes-and-selection-issues-for-salvage-focal-therapy-after-radiorecurrence/2485752/A recent study describes long-term follow-up comparing salvage focal ablative therapy with salvage radical prostatectomy in men with biopsy-confirmed, localized rec
- Rising cSCC and CIS Incidence in Denmark: Registry Findings (2005–2023)https://reachmd.com/news/rising-cscc-and-cis-incidence-in-denmark-registry-findings-20052023/2485721/A nationwide Danish registry report spanning 2005–2023 described
- FDA Approves Once‑Monthly SC RYBREVANT FASPRO: Implications for Clinic Operationshttps://reachmd.com/news/fda-approves-oncemonthly-sc-rybrevant-faspro-implications-for-clinic-operations/2485706/A J
- Dysplasia Grade and Colorectal Cancer risk in IBD: Cohort Summaryhttps://reachmd.com/news/dysplasia-grade-and-colorectal-cancer-risk-in-ibd-cohort-summary/2485704/An analysis of a Swedish registry cohort reported that the histologic grade at first detection of colorectal dysplasia in peopl
- Neuronal IDOL deletion links LDLR/APOE regulation to reduced amyloid and synaptic changeshttps://reachmd.com/news/neuronal-idol-deletion-links-ldlrapoe-regulation-to-reduced-amyloid-and-synaptic-changes/2485688/A long-running puzzle in Alzheimer’s research is how to translate the genetics of risk into levers clinicians might one day pull. Apolipoprotein E sits at the center of that puzzle. APOE genotype—especially ε4—remains the most powerful common genetic risk factor for
- Pooled KALOS/LOGOS Phase III readout: BREZTRI in uncontrolled asthmahttps://reachmd.com/news/pooled-kaloslogos-phase-iii-readout-breztri-in-uncontrolled-asthma/2485689/
- Preclinical Insights Into CD4+ CAR-T Targeting Amyloid Beta in Alzheimer's Diseasehttps://reachmd.com/news/preclinical-cd4-cart-alzheimers/2485677/A recent preclinical study used CD4+ CAR‑T cells engineered to recognize fibrillar amyloid‑β (Aβ) plaques, evaluated in the 5xFAD mouse model of rapid amyloid accumulation. The researchers describe a comparison of stable